Study of Aripiprazole in Subjects With Alcoholism

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Alcoholism
Interventions
DRUG

Aripiprazole

Tablets, Oral, 2-30mg, Once daily, 12 weeks.

DRUG

Placebo

Tablets, Oral, Once daily, 12 weeks.

Trial Locations (14)

Unknown

Local Institution, Farmington

Local Institution, New Haven

Local Institution, Indianapolis

Local Institution, Boston

Local Institution, New York

Local Institution, Rochester

Local Institution, Chapel Hill

Local Institution, Philadelphia

Local Institution, Providence

Local Institution, Charleston

Local Institution, Dallas

Local Institution, Houston

Local Institution, Charlottesville

Local Institution, Milwaukee

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00082199 - Study of Aripiprazole in Subjects With Alcoholism | Biotech Hunter | Biotech Hunter